Emergent BioSolutions provides contract manufacturing services for both bulk drug substances and sterile injectable drug products. Emergent’s state-of-the-art, single-use BDS facility enables turnkey upstream and downstream support for microbial, mammalian, and viral cell lines. Emergent’s Fill/Finish service offering comprises of vials and syringes, for both liquid and lyophilized products (including lyo cycle development). Emergent’s manufacturing facilities (located in Baltimore, MD) currently produce 20 commercial products, and a host of clinical stage (Phase 1 – 3) programs.

Learn more here>>>>>